Glass Health

Overview
News
Clinical Decision Support Systems?
Product stageSegments
Seed
?
Diagnostic support
?

Glass Health is a healthcare technology company that has developed an artificial intelligence (AI) tool to assist medical professionals in suggesting medical diagnoses and treatment plans. The company's AI system leverages large language models (LLMs) and connects them with clinical guidelines created and peer-reviewed by an academic physician team.

The AI tool analyzes patient summaries, including demographics, medical history, signs and symptoms, laboratory findings, and radiology results, and provides five to ten potential diagnoses for further investigation. Additionally, it can draft case assessments with explanations about relevant diagnostic studies, which clinicians can edit and incorporate into clinical notes and records or share with the broader medical community.

Glass Health's AI aims to prioritize the needs of patients and clinicians by leveraging cutting-edge technology to improve the practice of medicine. The company recognizes the documentation burden and time constraints faced by healthcare providers and aims to alleviate these challenges through its AI-powered solution.

While concerns have been raised about the reliability and accuracy of AI-generated health advice, Glass Health emphasizes that its AI is designed to act as an assistant, offering recommendations to consider rather than replacing clinical judgment. The company claims to have tight control over the information and guidelines used by its AI to generate outputs, aiming to reflect state-of-the-art medical knowledge and address potential biases.

Glass Health has gained significant traction, with over 59,000 users signed up for its platform. The company offers a direct-to-clinician monthly subscription and plans to pilot an electronic health record-integrated enterprise offering in the near future.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
San Francisco CA USA
Founded year:
2021
Employees:
1-10
IPO status:
Private
Total funding:
USD 7.0 mn
Last Funding:
USD 5.0 mn (Seed; Sep 2023)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.